RARA and acute promyelocytic leukemia: All-trans retinoic acid (ATRA) and arsenic trioxide (ATO), especially when combined compared to either one alone, are the most effective drugs for the treatment of APL, which induce the degradation of chimeric oncoprotein PML/RARα and APL cell differentiation [3, 4].